Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
1826843-8 1-5
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
-
General Information
Version
3.0
Revision date
2024-09-01
Product name
Trastuzumab deruxtecan for Injection 100mg
1.2.2. Uses advised against
Use for research and / or commercial
Manufacturer Name
DAIICHI SANKYO CO., LTD
Emergency telephone
+81-(0)3-6225-1111
Icons in SDS
Company Information
company name
DAIICHI SANKYO CO., LTD
e-mail address of the competent person responsible for the Safety Data Sheet
contact_sds@daiichisankyo.co.jp
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H341: Suspected of causing genetic defects. H360: May damage fertility or the unborn child.
Prevention
P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P280: Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. [Emergency response] P308+P313 IF exposed or concerned Get medical advice/attention.
Storage
P405: Store locked up.
Disposal
P501: Dispose of contents/ container in accordance with related laws and local/ regional regulations.
Additional information
Not applicable
2.1 Classification of the substance or mixture
Classification in accordance with Regulation (EC) No 1272/2008: Muta.2:H341 Repr.1B:H360
